Compare SCL & INNV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SCL | INNV |
|---|---|---|
| Founded | 1932 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Package Goods/Cosmetics | Medical/Nursing Services |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 1.2B |
| IPO Year | 1994 | 2021 |
| Metric | SCL | INNV |
|---|---|---|
| Price | $56.85 | $12.11 |
| Analyst Decision | Strong Buy | Sell |
| Analyst Count | 1 | 1 |
| Target Price | ★ $75.00 | $7.00 |
| AVG Volume (30 Days) | 149.3K | ★ 479.1K |
| Earning Date | 04-28-2026 | 05-05-2026 |
| Dividend Yield | ★ 3.23% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $1,803,737,000.00 | $853,699,000.00 |
| Revenue This Year | $6.60 | $12.85 |
| Revenue Next Year | $5.27 | $8.88 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 11.76 |
| 52 Week Low | $41.82 | $3.13 |
| 52 Week High | $68.00 | $12.64 |
| Indicator | SCL | INNV |
|---|---|---|
| Relative Strength Index (RSI) | 66.96 | 85.16 |
| Support Level | $49.36 | $7.33 |
| Resistance Level | $68.00 | N/A |
| Average True Range (ATR) | 1.63 | 0.67 |
| MACD | 0.24 | 0.27 |
| Stochastic Oscillator | 97.01 | 86.63 |
Stepan Co manufactures and sells a variety of chemicals and chemical-based products. The company organizes itself into three segments based on product type. The surfactants segment, which generates the majority of revenue, sells cleaning agents used in detergents, shampoos, body wash, fabric softeners, toothpastes, and other personal-care products. The polymers segment sells polyurethane used to manufacture rigid foam for thermal insulation, as well as phthalic anhydride used to make plastic components for the construction, automotive, and boating industries. The specialty products segment sells chemicals used in food and flavoring. The majority of Stepan's revenue comes from the United States, followed by France, Poland, the United Kingdom, Brazil, Mexico, and other countries.
InnovAge Holding Corp is a healthcare delivery platform comprising multiple participants focused on providing all-inclusive, capitated care to high-cost seniors, many of whom are dual-eligible. Its programs are designed to address two of the pressing challenges facing the U.S. healthcare industry: rising costs and poor outcomes. The purpose of the participant-centered care delivery approach is to improve the quality of care participants receive, while keeping them in their homes for as long as possible and reducing the overutilization of high-cost care settings, such as hospitals and nursing homes. The company manages its business as one reportable segment, PACE.